This fall we are lucky to be joined by three fabulous new interns at NLIRH. They will all be blogging for NV, NV. I’ll be introducing each of them with a quick interview this week and they will be begin blogging next week.
So to begin, welcome Angela Donadic, our Fall Policy and Advocacy Fellow!
What brings [...]
Archive for September, 2008
Introducing three new bloggers!
Posted in bloggers on September 24, 2008 | Leave a Comment »
Join Us for the Launch of NLIRH’s DC Office!
Posted in Uncategorized on September 24, 2008 | Leave a Comment »
NLIRH has launched a DC office and we would like for you to join us for an Open House! Below is the information:
The Moriah Fund
is pleased to invite you to the launch of
The Washington, DC Office of the
National Latina Institute for Reproductive Health (NLIRH)
Join us for a briefing and discussion on NLIRH’s new [...]
HPV vaccine added to required list of vaccines for immigrant women
Posted in Immigration, cervical cancer on September 23, 2008 | 4 Comments »
Jessica Gonzalez-Rojas, Director of Policy and Advocacy at NLIRH, wrote this piece for RH Reality Check in response to the new requirements:
This July, the U.S. Citizenship and Immigration Services (USCIS) announced new requirements, including five new vaccinations for individuals seeking adjustment of immigration status. One of these vaccinations is Gardasil, the human papillomavirus (HPV) vaccine. [...]
The Case for Reproductive Justice
Posted in Abortion, Reproductive Justice on September 22, 2008 | Leave a Comment »
Contributed by Maria Elena Pérez, Director of Community Mobilization at NLIRH
I often get asked, “What is reproductive justice?” when I explain to others what we do here at the Latina Institute. I then explain that reproductive justice goes beyond reproductive health, which is about service provision, and reproductive rights, which deals with the legality of [...]
More controversy around HPV vaccine
Posted in HPV, cervical cancer on September 3, 2008 | 1 Comment »
The New York Times, in an article on August 20, 2008, questioned drug companies’ push of the HPV vaccine. The article looks at the extensive marketing campaign and lobbying efforts taken on by the makers of the HPV vaccine. The article states that indeed, “in many states where cervical cancer legislation has been considered, there [...]
